Friday 6 November 2026 Export GSK’s income statement to Excel — free account

GSK PLC Sponsored ADR

GSK Healthcare Drug Manufacturers General

GSK PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $43.1 billion, up 7.44% from fiscal 2024.

Revenue: +3.75%
EPS: −14.7%
Free cash flow: +62.4%
Total debt: +33.2%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

49.68 0.73 −1.45%

Follow GSK

Alert me

Market cap: $101.0B
P/E: 16.7×
Fwd P/E: 14.6×
Dividend yield: 3.60%
F-score: 9/9
Altman Z: 2.12
Beneish M: −2.46
Dividend safety: 54/100

Overview

GSK PLC Sponsored ADR (GSK) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, GSK PLC Sponsored ADR (GSK) trades at a P/S ratio of 2.2×. Over the past ten years it has ranged from 1.2× (September 2022) to 3.1× (December 2019); the current reading is higher than 46% of that period. That is below the Drug Manufacturers General industry median of 3.5× and below the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/GSK/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="GSK PLC Sponsored ADR P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/GSK/metrics/ps-ratio">GSK PLC Sponsored ADR (GSK) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	2.3×	34.10%
FY2024	1.7×	(14.64%)
FY2023	2.0×	2.85%
FY2022	2.0×	(16.72%)
FY2021	2.4×	12.47%
FY2020	2.1×	(22.46%)
FY2019	2.7×	18.18%
FY2018	2.3×	(1.60%)
FY2017	2.3×	(7.68%)
FY2016	2.5×	17.88%

Period	P/S ratio	Change
Sep 2026	2.1×	(9.10%)
Jun 2026	2.4×	(6.55%)
Mar 2026	2.5×	9.69%
Dec 2025	2.3×	11.35%
43 more quarters	Free account

Against its own ten years

Low 1.2× High 3.1×

Ten-year median 2.3×

Current reading's percentile 47

Company	P/S ratio
SNY Sanofi compare	1.9×
GSK GSK PLC Sponsored ADR	2.2×
BMY Bristol Myers Squibb Company compare	2.6×
PFE Pfizer Inc. compare	2.7×
NVO Novo Nordisk A/S compare	3.5×
BIIB Biogen Inc. compare	3.5×
AZN AstraZeneca PLC compare	4.7×
AMGN Amgen Inc. compare	6.4×
GILD Gilead Sciences, Inc. compare	6.7×
Drug Manufacturers General industry median	3.5×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

GSK PLC Sponsored ADR (GSK) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on GSK

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on GSK

Stockrow Weekly